SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-17-007229
Filing Date
2017-10-02
Accepted
2017-10-02 08:09:47
Documents
6
Period of Report
2017-09-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K f8-k.htm 8-K 70443
2 EX-4.1 ex-4d1.htm EX-4.1 117656
3 EX-4.2 ex-4d2.htm EX-4.2 183266
4 EX-10.1 ex-10d1.htm EX-10.1 1052469
5 EX-99.1 ex-99d1.htm EX-99.1 26798
6 GRAPHIC ex-10d1g001.jpg GRAPHIC 15219
  Complete submission text file 0001558370-17-007229.txt   1472994
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35050 | Film No.: 171113101
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences